Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoinositide 3-kinase alpha (PI3Kα) is a lipid kinase involved in key cellular processes such as growth, proliferation, survival, and metabolism. It is a heterodimer consisting of a catalytic subunit p110α (encoded by the PIK3CA gene) and a regulatory subunit p85. PI3Kα phosphorylates PIP2 to produce PIP3, leading to AKT activation and downstream signaling. Aberrant activation or mutation of PI3Kα is frequently observed in various cancers, making it an important therapeutic target.
Inhibition of PI3Kα kinase activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoinositide 3-kinase alpha (PI3Kα).